Skip to main content

Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation

  • The original article was published in Multiple Sclerosis and Demyelinating Disorders 2017 2:3

Correction to: Multiple Sclerosis and Demyelinating Disorders (2017) 2:3.

https://doi.org/10.1186/s40893-017-0020-8

After publication of the article [1], it has been brought to our attention that the full funding acknowledgement is missing from the original article. It should also include the following –

“This work was supported by the Instituto de Salud Carlos III with FEDER funds (Otra forma de hacer Europa) from the European Commission (FIS: PI12/01823)”.

Reference

  1. 1.

    Moreno B, Vila G, Fernandez-Diez B, Vázquez R, di Penta A, Errea O, et al. Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation. Multiple Sclerosis and Demyelinating Disorders. 2017;2(1).

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Pablo Villoslada.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Moreno, B., Vila, G., Fernandez-Diez, B. et al. Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation. Mult Scler Demyelinating Disord 4, 3 (2019). https://doi.org/10.1186/s40893-019-0040-7

Download citation